
News
Read the latest news from Sciad and our clients
Client News
Client News
Synpromics Unveils Next Generation Liver Selective and Tunable Promoter Platform
17th October 2018
Client News
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards
12th October 2018
Sciad News
Sciad News
BioForward 2018: Growing Life Science in Birmingham
11th October 2018
Client News
Client News
Pharma Integrates 2018: 12–13 November
9th October 2018
Client News
Solentim Wins Two Queen’s Awards for Enterprise
Client News
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards
12th October 2018
Sciad News
Sciad News
BioForward 2018: Growing Life Science in Birmingham
11th October 2018
Client News
Client News
Pharma Integrates 2018: 12–13 November
9th October 2018
Client News
Solentim Wins Two Queen’s Awards for Enterprise
Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation
8th October 2018 Client News Client News Riffyn launches Open Access for scientists at non-profits To celebrate the ground-breaking publication of Riffyn SDE in the journal Scientific Data, Riffyn is launching Open Access which provides free use of the SDE for next-generation design and publishing of experiments 3rd October 2018 Client News Client News Innovate UK Awards Medherant a Medicines Manufacturing Grant New funding to support manufacture of transdermal patches for clinical trials 3rd October 2018 Client News Client News SynbiCITE launches new five-year strategy 2nd October 2018 Client News Client News New study shows how academics are the driving force in oncology R&D Talent pipeline struggling to keep up with demand 2nd October 2018 Client News Client News Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs 27th September 2018Loading
Got an innovation you need bringing to life?
We’d love to hear from you! Head to our contact page to start a conversation.
